Uncovers how nanocurcumin restores gut microbiota viability affected by malathion exposure, indicating its protective potential.
The gut microbiota is a diverse and dynamic microbial ecosystem playing a pivotal role in nutrient metabolism, immune regulation, and overall host physiology. Disruption of this microbial balance, or dysbiosis, has been implicated in a range of diseases. Among environmental toxicants, organophosphate pesticides such as malathion are recognized for their potential to alter gut microbial communities; however, the specific effects on probiotic strains have not been fully elucidated. In this study, the influence of malathion on selected probiotic strains — Lactobacillus rhamnosus ( L. rhamnosus) , Lactobacillus plantarum ( L. plantarum) , L. rhamnosus LB21, L. plantarum 299v, and Bacillus coagulans ( B . coagulans )— were evaluated using 2,3,5-triphenyltetrazolium chloride (TTC) assay to assess metabolic activity and colony-forming unit (CFU) assay to measure viability. The malathion exposure resulted in a concentration-dependent decline in both parameters, with L. rhamnosus being the most susceptible. To counteract the observed toxicity, nanocurcumin was synthesized via sonication-assisted process, yielding particles averaging 29 nm in size and exhibiting a zeta potential of –75.8 mV. The antioxidant assays confirmed high radical scavenging activity (IC 50 = 19.91 μg/ml) and ferric reducing capacity of nanocurcumin comparable to that of ascorbic acid. The co-treatment with nanocurcumin significantly improved the viability and metabolic activity of malathion-stressed probiotic strains, particularly L. rhamnosus LB21, which demonstrated substantial recovery. These findings suggest that malathion exerts harmful effects on beneficial gut microbes, and nanocurcumin may serve as a protective and restorative agent to mitigate pesticide-induced microbial dysbiosis. • Malathion caused a concentration-dependent reduction in metabolic activity and viability of selected gut microbiota, with Lactobacillus rhamnosus showing the highest susceptibility. • Bacillus coagulans demonstrated greater tolerance to malathion, indicating species-specific resilience among selected gut microbiota. • Nanocurcumin nanoparticles (∼29 nm, −75.8 mV) exhibited strong stability and potent antioxidant activity, supporting their protective potential. • Nanocurcumin enhanced the metabolic activity of all selected gut microbiota, with the greatest stimulation observed in L. rhamnosus LB21. • Co-treatment with nanocurcumin effectively restored malathion-induced damage in selected gut microbiota, significantly improving TTC activity and CFU counts.
No takes yet. Share an insight, caveat, or question.
AlSosowaa et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: